Interferon-Free Hepatitis C Tx Hits Snag
SEATTLE (MedPage Today) — Results in a hard-to-treat patient population have clouded the future of a closely watched agent that acts against hepatitis C directly.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com